19 November 2016 - At an EY forum on Friday, the CEO of Regeneron Pharmaceuticals acknowledged that “really bad actors” have posed a problem for the drug industry.

“We have a few bad actors that have raised prices for no reason, just because they could, not because they innovated anything,” Regeneron CEO Len Schleifer said at the EY panel. “We have to weed those people out without destroying the industry, which I think has to succeed or the health of the nation and the world will suffer.”

Schleifer was responding to a question from the moderator, Harvard Business Review Group Editor-in-Chief Adi Ignatius, about how Schleifer succeeds in a challenging industry that’s facing increasing pressure to bring prices down.

Read Yahoo Finance article